Francesco E. Boccalatte
Francesco E. Boccalatte
Postdoctoral Fellow, NYU School of Medicine
Email verificata su nyumc.org
Titolo
Citata da
Citata da
Anno
Attenuation of miR-126 activity expands HSC in vivo without exhaustion
ER Lechman, B Gentner, P Van Galen, A Giustacchini, M Saini, ...
Cell stem cell 11 (6), 799-811, 2012
1642012
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes
R Piva, E Pellegrino, M Mattioli, L Agnelli, L Lombardi, F Boccalatte, ...
The Journal of clinical investigation 116 (12), 3171-3182, 2006
1582006
The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration
C Voena, C Conte, C Ambrogio, EB Erba, F Boccalatte, S Mohammed, ...
Cancer research 67 (9), 4278-4286, 2007
972007
Efficient ex vivo engineering and expansion of highly purified human hematopoietic stem and progenitor cell populations for gene therapy
E Zonari, G Desantis, C Petrillo, FE Boccalatte, MR Lidonnici, ...
Stem cell reports 8 (4), 977-990, 2017
852017
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis …
FE Boccalatte, C Voena, C Riganti, A Bosia, L D'Amico, L Riera, M Cheng, ...
Blood, The Journal of the American Society of Hematology 113 (12), 2776-2790, 2009
552009
The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cells
B King, F Boccalatte, K Moran-Crusio, E Wolf, J Wang, C Kayembe, ...
Nature immunology 17 (11), 1312, 2016
382016
miRNA-126 orchestrates an oncogenic program in B cell precursor acute lymphoblastic leukemia
S Nucera, A Giustacchini, F Boccalatte, A Calabria, C Fanciullo, T Plati, ...
Cancer cell 29 (6), 905-921, 2016
332016
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1
C Voena, F Di Giacomo, E Panizza, L D'amico, FE Boccalatte, ...
Oncogenesis 2 (4), e43-e43, 2013
292013
MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia
B Gentner, N Pochert, A Rouhi, F Boccalatte, T Plati, T Berg, SM Sun, ...
Experimental hematology 43 (10), 858-868. e7, 2015
262015
Assessment of tocilizumab in the treatment of cancer cachexia
A Berti, F Boccalatte, MG Sabbadini, L Dagna
Journal of Clinical Oncology 31 (23), 2970-2970, 2013
242013
Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia
A Kloetgen, P Thandapani, P Ntziachristos, Y Ghebrechristos, S Nomikou, ...
Nature Genetics 52 (4), 388-400, 2020
122020
Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL
S Rodriguez, C Abundis, F Boccalatte, P Mehrotra, MY Chiang, MA Yui, ...
Leukemia 34 (5), 1241-1252, 2020
42020
Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion
Y Xiu, Q Dong, L Fu, A Bossler, X Tang, B Boyce, N Borcherding, ...
Blood, The Journal of the American Society of Hematology 135 (2), 108-120, 2020
32020
Dynamic 3D chromosomal landscapes in acute leukemia
A Kloetgen, P Thandapani, P Ntziachristos, Y Ghebrechristos, S Nomikou, ...
bioRxiv, 724427, 2019
32019
Tyrosine phosphorylation sites
P Hornbeck, A Guo, TL Gu, K Rikova, A Moritz, C Farnsworth, M Stokes, ...
US Patent App. 12/150,903, 2009
32009
Tyrosine phosphorylation sites
P Hornbeck, F Boccalatte, C Farnsworth, V Goss, TL Gu, A Guo, Y Li, ...
US Patent App. 12/157,179, 2009
22009
Tyrosine phosphorylation sites
P Hornbeck, A Guo, K Rikova, A Moritz, E Spek, A Possemato, ...
US Patent App. 12/311,464, 2010
12010
155 EML4-ALK signaling is required for the maintenance of neoplastic phenotype of non-small cell lung cancer cells: novel strategy for lung cancer tailored therapies
C Voena, E Panizza, E Pellegrino, L D'Amico, FE Boccalatte, B Ruggeri, ...
Ejc Supplements 7 (8), 54, 2010
12010
Lung-derived HMGB1 is detrimental for vascular remodeling of metabolically imbalanced arterial macrophages
L Boytard, T Hadi, M Silvestro, H Qu, A Kumpfbeck, R Sleiman, KH Fils, ...
Nature communications 11 (1), 1-17, 2020
2020
Methods for genetic modification of stem cells
L Naldini, BR Gentner, E Zonari, F Boccalatte
US Patent 10,617,721, 2020
2020
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20